Cardio Diagnostics announced that it received a notification letter from the Listing Qualifications Department of Nasdaq notifying the company that it had regained compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rule 5550 for continued listing on The Nasdaq Capital Market.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CDIO:
- Cardio Diagnostics unveils PrecisionCHD Epigenetic Test in JAHA
- Cardio Diagnostics gets contract from Vizient for heart disease tests, no terms
- Cardio Diagnostics Aimil team on detection and management of CHD in India
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue